U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06860360) titled 'Artificial Intelligence for the Analysis of Video Data of Facial Movement, with a Focus on Myasthenia Gravis' on Aug. 03, 2022.

Brief Summary: Rationale: Myasthenia Gravis (MG) is an autoimmune disorder (AID) with antibodies against the NMJ, resulting in various degrees of muscle fatigability and weakness. All striated muscles can be involved, although the extra-ocular muscles are most commonly affected, giving rise to a fluctuating ptosis and diplopia. Facial muscles are also commonly affected, resulting in eye closure weakness, difficulty chewing and swallowing or speech impairments. Antibodies against the acetylcholine receptor (...